Is Hims & Hers Health Stock Still a Buy After Strong Earnings?
In this video, I will be talking about Hims & Hers‘ (NYSE: HIMS) recent earnings report and why the stock might still be a buy right now despite being up 25% this year already.
*Stock prices used were from the trading day of Feb. 26, 2024. The video was published on Feb. 26, 2024.
Should you invest $1,000 in Hims & Hers Health right now?
Before you buy stock in Hims & Hers Health, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Hims & Hers Health wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
*Stock Advisor returns as of February 26, 2024
Neil Rozenbaum has positions in Hims & Hers Health. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Neil is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
Is Hims & Hers Health Stock Still a Buy After Strong Earnings? was originally published by The Motley Fool